- Home
- AU vs MEDP Comparison
AU vs MEDP Comparison
Compare AU & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AU
- MEDP
- Stock Information
- Founded
- AU 1944
- MEDP 1992
- Country
- AU United States
- MEDP United States
- Employees
- AU N/A
- MEDP N/A
- Industry
- AU Precious Metals
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- AU Basic Materials
- MEDP Health Care
- Exchange
- AU Nasdaq
- MEDP Nasdaq
- Market Cap
- AU 10.3B
- MEDP 11.7B
- IPO Year
- AU 1972
- MEDP 2016
- Fundamental
- Price
- AU $24.00
- MEDP $349.02
- Analyst Decision
- AU Hold
- MEDP Buy
- Analyst Count
- AU 5
- MEDP 10
- Target Price
- AU $31.75
- MEDP $389.00
- AVG Volume (30 Days)
- AU 4.8M
- MEDP 277.5K
- Earning Date
- AU 11-07-2024
- MEDP 02-10-2025
- Dividend Yield
- AU 0.91%
- MEDP N/A
- EPS Growth
- AU N/A
- MEDP 33.84
- EPS
- AU 1.34
- MEDP 11.42
- Revenue
- AU $5,299,000,000.00
- MEDP $2,070,866,000.00
- Revenue This Year
- AU $31.43
- MEDP $14.01
- Revenue Next Year
- AU $21.09
- MEDP $5.86
- P/E Ratio
- AU $18.30
- MEDP $30.54
- Revenue Growth
- AU 17.78
- MEDP 16.24
- 52 Week Low
- AU $15.80
- MEDP $277.72
- 52 Week High
- AU $32.57
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- AU 39.78
- MEDP 52.65
- Support Level
- AU $23.47
- MEDP $340.06
- Resistance Level
- AU $27.22
- MEDP $359.49
- Average True Range (ATR)
- AU 0.60
- MEDP 9.00
- MACD
- AU -0.07
- MEDP 0.55
- Stochastic Oscillator
- AU 12.27
- MEDP 43.31
About AU AngloGold Ashanti PLC
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.